Bank of Montreal
RCKT icon

Bank of Montreal’s Rocket Pharmaceuticals RCKT Stock Holding History

Bank of Montreal’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
70,399
-8,159
-10% -$27.1K ﹤0.01% 2894
2026
Q1 		$281K Buy
78,558
+3,248
+4% +$12.9K ﹤0.01% 2715
2025
Q4 		$264K Sell
75,310
-1,211
-2% -$4.15K ﹤0.01% 2673
2025
Q3 		$249K Buy
76,521
+2,721
+4% +$8.57K ﹤0.01% 2641
2025
Q2 		$181K Buy
+73,800
New +$374K ﹤0.01% 2843
2024
Q1 		– Sell
-279
Closed -$8.62K – 4245
2023
Q4 		$8.62K Sell
279
-731
-72% -$16.1K ﹤0.01% 3817
2023
Q3 		$23.8K Buy
+1,010
New +$18.4K ﹤0.01% 3541
2021
Q2 		– Sell
-3,001
Closed -$128K – 4677
2021
Q1 		$128K Sell
3,001
-3,601
-55% -$198K ﹤0.01% 3290
2020
Q4 		$365K Buy
6,602
+3,691
+127% +$135K ﹤0.01% 2880
2020
Q3 		$74K Sell
2,911
-1,148
-28% -$28.3K ﹤0.01% 3245
2020
Q2 		$96K Buy
4,059
+4,006
+7,558% +$72.2K ﹤0.01% 3113
2020
Q1 		$1K Sell
53
-3,724
-99% -$73.7K ﹤0.01% 3975
2019
Q4 		$86K Buy
3,777
+1,169
+45% +$19.5K ﹤0.01% 3576
2019
Q3 		$30K Buy
2,608
+102
+4% +$1.27K ﹤0.01% 3867
2019
Q2 		$38K Buy
+2,506
New +$43.7K ﹤0.01% 3819
2019
Q1 		– Sell
-293
Closed -$4K – 4662
2018
Q4 		$4K Buy
293
+149
+103% +$2.47K ﹤0.01% 4181
2018
Q3 		$4K Sell
144
-6,972
-98% -$151K ﹤0.01% 4175
2018
Q2 		$139K Buy
7,116
+148
+2% +$2.8K ﹤0.01% 2962
2018
Q1 		$130K Buy
+6,968
New +$114K ﹤0.01% 2854
2017
Q1 		– Sell
-1,250
Closed -$32K – 4155
2016
Q4 		$32K Sell
1,250
-1,000
-44% -$28.5K ﹤0.01% 3255
2016
Q3 		$85K Hold
2,250
– – ﹤0.01% 2864
2016
Q2 		$67K Hold
2,250
– – ﹤0.01% 2967
2016
Q1 		$67K Hold
2,250
– – ﹤0.01% 2948
2015
Q4 		$102K Hold
2,250
– – ﹤0.01% 2764
2015
Q3 		$85K Buy
+2,250
New +$103K ﹤0.01% 2705

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal's RCKT Position: Q2 2026 in Review

Bank of Montreal reduced its Rocket Pharmaceuticals (RCKT) stake by 10% in Q2 2026, selling an estimated $27.1K and leaving 70,399 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

Bank of Montreal first reported a position in RCKT in Q3 2015 and has held it in 25 quarters since. The position peaked at $365K in Q4 2020. 164 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Bank of Montreal held 70,399 shares of Rocket Pharmaceuticals worth $241K as of Q2 2026.
  • Bank of Montreal sold 8,159 Rocket Pharmaceuticals shares in Q2 2026, an estimated $27.1K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2894 holding.
  • Bank of Montreal first reported a position in Rocket Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
  • Bank of Montreal's Rocket Pharmaceuticals position peaked at $365K in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.